Enhancing small diameter tissue engineered vascular grafts with heparin and hepatocyte growth factor: A promising approach
{{output}}
Currently, there is often a lack of suitable small-caliber graft vessels for treating cardiovascular diseases because of thrombosis and intimal hyperplasia. Tissue engineered vascular grafts (TEVGs) promise a potential solution to this issue. Acellular vascula... ...
